Survey: 94% of Germans Who Consumed Cannabis Did So for Medical Reasons – Ganjapreneur | How to buy Skittles Moonrock online

According to a Survey According to a study by the German medical cannabis company Bloomwell GmBh 94% of respondents who consumed cannabis did so because they had a medical or health purpose. Respondents cited stress relief as the most common reason for using cannabis (about 60%), followed by sleeping disorders (50.4%) and pain relief (35%).

Just 10% of respondents claimed to have purchased cannabis exclusively from licensed pharmacists in the past year. The vast majority, 79.6%, said that they had had negative experiences dealing with the unlicensed marketplace.

Niklas Kouparanis said in a statement that the survey results show the “immensity of potential and growth room of the rapidly expanding medical marijuana industry of Germany following the implementation of Cannabis Act on April 1st, 2024 which rescheduled Cannabis as a nonnarcotic.”

The survey revealed that 30.9% of respondents reported buying cannabis of poor quality. 29% feared that cannabis illegally obtained will negatively impact their health. 39.7% are worried about unwanted side effects of illegally purchased cannabis. 14.8% admitted to having problems with dosing. And 26.3% said they bought contaminated cannabis.

The survey also revealed that 91.7% said they would prefer to receive cannabis treatment via an application, which includes delivery of medical marijuana from a German pharmacies at low prices. Kouparanis stated that “Patients do not need to rely on illicit markets and should also not be pushed that way.”

The survey also found that a third of consumers had been diagnosed by a qualified medical condition, and 21.2% already spoke to a physician about medical cannabis but the doctor didn’t prescribe it to them as a form of treatment. More than a quarter (25.2%) of respondents said that doctors could not help them with their health issues, while only 9.2 percent had “no problem” finding a qualified doctor to support their medical cannabis therapy.

Dr. Julian Wichmann M.D. Co-Founder of Bloomwell Group, and CEO of Bloomwell noted that “findings underscored the need for medical marijuana to be treated as an equal with other modern medical treatments.”

Wichmann added, “Medical cannabis is still taboo for too many German doctors.” “Education on cannabis medical treatment is necessary, not only for patients but also for doctors, in order to normalize the use and dispel outdated stereotypes.”

Get daily cannabis industry news updates. Subscribe to our Newsletter

Our partners make Ganjapreneur possible:

Create a profile View all Categories